Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew L Mason

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
Nature Genetics|July 20, 2010
Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosisGideon M Hirschfield, Xiangdong Liu, Younghun Han, et al.
Gut|December 18, 2019
Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitisMaren H Harms, Rozanne C de Veer, Willem J Lammers, et al.
The American Journal of Gastroenterology|July 25, 2024
Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver TransplantationBishoi Aziz, Beverley Kok, Matthew Cheah, et al.
The American Journal of Gastroenterology|December 13, 2017
Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and OutcomeMaren H Harms, Willem J Lammers, Douglas Thorburn, et al.
The American Journal of Gastroenterology|January 31, 2025
Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver TransplantationBishoi Aziz, Beverley Kok, Matthew Cheah, et al.
Gastroenterology|October 9, 2018
Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient SurvivalAldo J Montano-Loza, Bettina E Hansen, Christophe Corpechot, et al.
Nature Chemical Biology|November 10, 2021
Sialic acid-containing glycolipids mediate binding and viral entry of SARS-CoV-2Linh Nguyen, Kelli A McCord, Duong T Bui, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 17, 2019
Factors Associated With Progression and Outcomes of Early Stage Primary Biliary CholangitisNikolaos K Gatselis, Jorn C Goet, Kalliopi Zachou, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 17, 2025
Development of a Question Prompt List for People Living With Primary Biliary Cholangitis: A Delphi StudyEllen Werner, Maria C B van Hooff, Gemma H X Weijsters, et al.
Gastroenterology|August 12, 2015
Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid TherapyWillem J Lammers, Gideon M Hirschfield, Christophe Corpechot, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Nature Genetics|July 20, 2010
Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosisGideon M Hirschfield, Xiangdong Liu, Younghun Han, et al.
Gut|December 18, 2019
Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitisMaren H Harms, Rozanne C de Veer, Willem J Lammers, et al.
The American Journal of Gastroenterology|July 25, 2024
Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver TransplantationBishoi Aziz, Beverley Kok, Matthew Cheah, et al.
The American Journal of Gastroenterology|December 13, 2017
Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and OutcomeMaren H Harms, Willem J Lammers, Douglas Thorburn, et al.
The American Journal of Gastroenterology|January 31, 2025
Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver TransplantationBishoi Aziz, Beverley Kok, Matthew Cheah, et al.
Gastroenterology|October 9, 2018
Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient SurvivalAldo J Montano-Loza, Bettina E Hansen, Christophe Corpechot, et al.
Nature Chemical Biology|November 10, 2021
Sialic acid-containing glycolipids mediate binding and viral entry of SARS-CoV-2Linh Nguyen, Kelli A McCord, Duong T Bui, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 17, 2019
Factors Associated With Progression and Outcomes of Early Stage Primary Biliary CholangitisNikolaos K Gatselis, Jorn C Goet, Kalliopi Zachou, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 17, 2025
Development of a Question Prompt List for People Living With Primary Biliary Cholangitis: A Delphi StudyEllen Werner, Maria C B van Hooff, Gemma H X Weijsters, et al.
Gastroenterology|August 12, 2015
Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid TherapyWillem J Lammers, Gideon M Hirschfield, Christophe Corpechot, et al.
Pageof 11